Search results
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 5 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Namita Thapar's Emcure Pharmaceuticals IPO opens today: All you need to know
Hindustan Times· 4 days agoEmcure IPO: The price range of the IPO is ₹960-1,008 per share and investors can bid for 14 shares...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?
The Economic Times· 4 days agoAhead of the issue opening, the company raised Rs 582 crore from anchor investors. Marquee investors...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 4 days agoThe Shark Tank India fame Namita Thapar-backed company is offering its shares in the range of Rs...
Emcure has better listed pharma alternatives
The Economic Times· 4 days agoPromoted by the family of Namita Thapar of the 'Shark Tank' fame, Emcure Pharma is the 13th largest player in the Indian pharmaceutical market. The...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 4 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Emcure Pharma On The Way To D-Street Debut; IPO On July 3
Free Press Journal· 6 days agoThe Initial Public Offer of 'Emcure Pharmaceutical's will begin accepting subscriptions on July 3. A...
Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details
The Economic Times· 2 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked over 13 times so far on the...
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 6 days agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Emcure Pharmaceuticals IPO opens on July 03; Here’s all you need to know
Financial Express· 4 days agoEmcure Pharma to open its IPO for bidding on July 03. The company backed by Bain Capital and...